Global /South Korea /Healthcare /Biotechnology /405000

Plasmapp Co., Ltd.

405000

• KRX: 405000 • Delayed

7,690KRW 0.3%

5.04 USD

As of 13 June 2026, Plasmapp Co., Ltd. has a market cap of $19.4M USD, ranking #37277 globally and #2364 in South Korea. It ranks #3345 in the Healthcare sector, and #657 in the Biotechnology industry.

Global Rank

37277

Country Rank

2364

Sector Rank

3345

Industry Rank

657

Key Stats

Market Cap

$19.4MUSD

29.51B KRW

Enterprise Value

$22.82MUSD

34.83B KRW

Revenue (TTM)

$5.58MUSD

8.48B KRW

EBITDA (TTM)

-$4.12MUSD

-6.29B KRW

Net Income (TTM)

-$4.33MUSD

-6.59B KRW

EBITDA Margin

-74%

Profit Margin

-78%

PS Ratio

3.5

PB Ratio

5.2

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Youbong Lim open_in_new

Founded

2015

Website

plasmapp.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.3%	-1.8%	2.1%	23%	-4.5%	32%	4.1%	-86%	-94%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	405000 주식회사 플라즈맵 Ordinary Shares ISIN: KR7405000001 Shares Out.: Shares Outstanding: 3.837M¹ Shares Float: 1.808M² TV: TradingView: KRX: 405000 SA: Stock Analysis: KRX: 405000 YF: Yahoo Finance: 405000.KS GF: Google Finance: KRX: 405000 BA: Barron's: 405000 MS: Morningstar: XKRX: 405000	7,690 KRW	TV: TradingView: KRX: 405000 SA: Stock Analysis: KRX: 405000 YF: Yahoo Finance: 405000.KS GF: Google Finance: KRX: 405000 BA: Barron's: 405000 MS: Morningstar: XKRX: 405000

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Plasmapp Co., Ltd.

Plasmapp Co., Ltd. develops, manufactures, and sells plasma sterilizers for medical tools. The company provides STERLINK sterilization system, a low-temperature plasma sterilization technology for medical operations; and instrument tracking systems, which is a real-time sterilization monitoring system. It also offers Actilink, a product lineup for plasma regenerative activator. The company was founded in 2015 and is based in Daejeon, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 231K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 145K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.37B 20.33T KRW 69K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.51B 8.37T KRW 28K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.99B 6.07T KRW 20K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.25B 3.42T KRW 12K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 940K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 824K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 246K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 218K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 218K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 142K%	-	United States

chevron_leftBack